The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!

Name: The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!
SKU: 25837
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 53 No. 1 Articles 2023 Tags: Ahmed Naguy, Bibi Alamiri, brilaroxazine, emraclidine, evenamide, ralmitaront, roluperidone, Saxby Pridmore, schizophrenia

Description

Description

Review Article

The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!

Ahmed Naguy, Saxby Pridmore, Bibi Alamiri

The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!

Description

Review Article

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Genetics of Schizophrenia: Recent Advances

The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!

Description

Review Article

Related products

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Clozapine Factors in Schizophrenia by Takefumi Suzuki

Ethical Issues In Schizophrenia: Considerations for Treatment and Research

Genetics of Schizophrenia: Recent Advances